Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.172EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.172EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.320EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.76EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.107EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.55EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDKEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.285EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.285EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.582EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.582EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.580EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used